Pickard and his colleagues have presented abnormally low levels of GAS5 expression in prostate cancer cells and GAS5 upregulation boosts apoptosis and reduces 22Rv1 cell survival (Pickard et al., 2013). Here, GAS5 is linked to prostate cancer.